ASPIRA.BO
Price:
$52.5
Market Cap:
$540.38M
Aspira Pathlab & Diagnostics Ltd. engages in the operation of diagnostic centers and laboratories. The firm involves in the pathological investigations of bio-chemistry, hematology, histopathology, microbiology, immune-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. Its services includes on-site and off-site evaluation of employee's health; on-site industry specific fast screening tests; management of employee data ensuring complete data security and privacy; and customized packages as per industry needs. The company was founded on July 3, 1973 and is headquartered in Navi Mumbai, India.
Industry
Medical - Care Facilities
IPO Date
Stock Exchange
BSE
Ticker
ASPIRA.BO
According to Aspira Pathlab & Diagnostics Limited’s latest financial reports and current stock price. The company's current ROE is 18.12%. This represents a change of 310.67% compared to the average of 4.41% of the last 4 quarters.
The mean historical ROE of Aspira Pathlab & Diagnostics Limited over the last ten years is -188.29%. The current 18.12% ROE has changed -109.62% with respect to the historical average. Over the past ten years (40 quarters), ASPIRA.BO's ROE was at its highest in in the September 2020 quarter at 29.53%. The ROE was at its lowest in in the March 2018 quarter at -409.41%.
Average
-188.29%
Median
-13.52%
Minimum
-1667.23%
Maximum
34.87%
Discovering the peaks and valleys of Aspira Pathlab & Diagnostics Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 3.69%
Maximum Annual ROE = 34.87%
Minimum Annual Increase = -6204.72%
Minimum Annual ROE = -1667.23%
Year | ROE | Change |
---|---|---|
2025 | 16.62% | -163.10% |
2024 | -26.34% | 3.69% |
2023 | -0.70% | -102.00% |
2022 | 34.87% | 109.93% |
2021 | 16.61% | -114.89% |
2020 | -111.57% | 11.75% |
2019 | -99.84% | -94.01% |
2018 | -1667.23% | 3.52% |
2017 | -46.06% | -6204.72% |
2016 | 0.75% | 16.76% |
The current ROE of Aspira Pathlab & Diagnostics Limited (ASPIRA.BO) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
-3.47%
5-year avg
8.21%
10-year avg
-188.29%
Aspira Pathlab & Diagnostics Limited’s ROE is
Company | ROE | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aspira Pathlab & Diagnostics Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Aspira Pathlab & Diagnostics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Aspira Pathlab & Diagnostics Limited's ROE?
How is the ROE calculated for Aspira Pathlab & Diagnostics Limited (ASPIRA.BO)?
What is the highest ROE for Aspira Pathlab & Diagnostics Limited (ASPIRA.BO)?
What is the 3-year average ROE for Aspira Pathlab & Diagnostics Limited (ASPIRA.BO)?
What is the 5-year average ROE for Aspira Pathlab & Diagnostics Limited (ASPIRA.BO)?
How does the current ROE for Aspira Pathlab & Diagnostics Limited (ASPIRA.BO) compare to its historical average?